chartexchange

ORMP
Oramed Pharmaceuticals Inc.
stockNASDAQ

At CloseNov 18, 2026 3:59:50 PM EST
3.89USD+0.517%(+0.02)164,339
After-hoursNov 18, 2026 4:00:30 PM EST
3.89USD0.000%(-0.00)
Loading…
Loading…
169.60M
Healthcare
Biotechnology
CEO
Nadav Kidron
HQ
New York, NY, USA
Previous Close
$3.87
Beta
1.19
52-Week High
$5.47 2026-08-27
52-Week Low
$2.38 2025-11-20
SMA 50
$4.30
SMA 200
$4.06
Avg. Vol 10D
157,222
Avg. Vol 30D
135,082
Avg. Vol 90D
172,152
Relative Vol
1.22
32.75M
0.6300%
3,703
Jan 16, 2026 · $0.250
Jan 23, 2013 · 1-for-12.0005 (reverse)
ORMP Profile

oramed pharmaceuticals (nasdaqcm:ormp) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 trials under the usfda, the company is seeking to revolutionize the treatment of diabetes. read more: http://www.oramed.com/investors/corporate-presentation watch: https://www.youtube.com/watch?v=5qchxtdv9eg

ORMP Performance
PeriodPriceDateChangeBeta
1W4.032026-11-12-3.23%-5.391
1M4.062026-10-19-3.94%1.133
3M4.792026-08-19-18.58%0.926
6M4.332026-05-19-9.93%0.801
1Y2.502025-11-19+56.31%1.189
2Y2.302024-11-19+69.56%—
5Y26.502021-11-19-85.28%1.143
ORMP Stock Summary

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) stock price today is $3.90, and today's volume is 164,339. ORMP is up 0.775% today. The 30 day average volume is 135,082. ORMP market cap is $169.60M with 43.49M shares outstanding.